4th Quarter - Report
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for GENERIC PHARMACEUTICAL ASSOCIATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
$40,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2015 | $40,000 | Replaced |
| 4th Quarter - Termination | Apr 3, 2017 | $40,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to FDA REMS
| Lobbyist | Covered position, as disclosed |
|---|---|
| NANCY L JOHNSON | — |
| LANCE B LEGGITT | — |
| SARA LOVE RAWLINGS | — |
| JENNIFER SUMMA | — |
Pharmacy PHA
Issues relating to biosimilar regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE B LEGGITT | — |
| SARA LOVE RAWLINGS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.